These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25316224)

  • 21. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
    Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
    Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study.
    Curtis B; Lage MJ
    J Med Econ; 2014 Jan; 17(1):21-31. PubMed ID: 24195723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C; Gilbride CJ
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association between side effects of oral anti-diabetic drugs and self-reported mental health and quality of life among patients with type 2 diabetes].
    Chen ZC; Zhang SL; Yan L; Wu MC; Chen LH; Ji LN
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):229-33. PubMed ID: 21418865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 diabetes mellitus in China: a preventable economic burden.
    Wang W; McGreevey WP; Fu C; Zhan S; Luan R; Chen W; Xu B
    Am J Manag Care; 2009 Sep; 15(9):593-601. PubMed ID: 19747024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.
    Mosnier-Pudar H; Hochberg G; Eschwege E; Virally ML; Halimi S; Guillausseau PJ; Peixoto O; Touboul C; Dubois C; Dejager S
    Diabetes Metab; 2009 Jun; 35(3):220-7. PubMed ID: 19303338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of patient attitudes and beliefs to insulin therapy upon initiation, and their attitudinal changes after initiation: the DAWN Japan study.
    Odawara M; Ishii H; Tajima N; Iwamoto Y
    Curr Med Res Opin; 2016; 32(4):681-6. PubMed ID: 26743676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of insulin therapy and attitudes towards insulin intensification among adults with type 2 diabetes: A qualitative study.
    Holmes-Truscott E; Browne JL; Speight J
    J Diabetes Complications; 2016 Aug; 30(6):1151-7. PubMed ID: 27114388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis.
    Stuckey H; Fisher L; Polonsky WH; Hessler D; Snoek FJ; Tang TS; Hermanns N; Mundet-Tuduri X; da Silva MER; Sturt J; Okazaki K; Cao D; Hadjiyianni I; Ivanova JI; Desai U; Perez-Nieves M
    BMJ Open Diabetes Res Care; 2019; 7(1):e000723. PubMed ID: 31908792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in physician and patient perceptions about insulin therapy for management of type 2 diabetes: the DAWN Japan study.
    Yoshioka N; Ishii H; Tajima N; Iwamoto Y;
    Curr Med Res Opin; 2014 Feb; 30(2):177-83. PubMed ID: 24128339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital and patient influencing factors of treatment schemes given to type 2 diabetes mellitus inpatients in Inner Mongolia, China.
    Zhang N; McNeil E; Assanangkornchai S; Fan Y
    F1000Res; 2016; 5():1577. PubMed ID: 27429746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus.
    Alidrisi HA; Bohan A; Mansour AA
    Cureus; 2021 Sep; 13(9):e18263. PubMed ID: 34712538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient and Physician Perspectives on the Use of a Connected Ecosystem for Diabetes Management: International Cross-Sectional Observational Study.
    Benito-Garcia E; Vega J; Daza EJ; Lee WN; Kennedy A; Chantelot JM
    JMIR Form Res; 2023 Nov; 7():e47145. PubMed ID: 38032701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of willingness to Tele-monitoring interventions in patients with type 2 diabetes and/or hypertension in the public primary healthcare setting.
    Sin DYE; Guo X; Yong DWW; Qiu TY; Moey PKS; Falk MR; Tan NC
    BMC Med Inform Decis Mak; 2020 Jan; 20(1):11. PubMed ID: 31992288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK.
    Roborel de Climens A; Pain E; Boss A; Shaunik A
    Diabetes Ther; 2020 Aug; 11(8):1873-1881. PubMed ID: 32533547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of fear of diabetes progression: A multi-center cross-sectional study for patients self-management and healthcare professions education.
    Wang Y; Yu Q; Zeng Z; Yuan R; Wang R; Chen J; Zhou H; Tang J
    Front Public Health; 2022; 10():910145. PubMed ID: 36600932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to initiation of insulin therapy in poorly controlled type 2 diabetes based on self-determination theory.
    Rajab A; Khaloo P; Rabizadeh S; Alemi H; Salehi S; Majdzadeh R; Mirmiranpour H; Rajab A; Esteghamati A; Nakhjavani M
    East Mediterr Health J; 2020 Nov; 26(11):1331-1338. PubMed ID: 33226100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran.
    Mostafavian Z; Ghareh S; Torabian F; Yazdi MS; Khazaei MR
    Data Brief; 2018 Jun; 18():2047-2050. PubMed ID: 29904712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Method of Diagnosis of Type 2 Diabetes Mellitus: Results from SHIELD.
    Rodbard HW; Green AJ; Fox KM; Grandy S
    Int J Endocrinol; 2009; 2009():796206. PubMed ID: 20011059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.